Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Vote on Oncology Nursing News' New Podcast Logo

      May 13, 2020
      By Brielle Benyon
      Article

      Oncology Nursing News is launching our very own podcast, and we want to hear from you when it comes to the logo and topics to cover.

      Oncology Nursing News is taking its existing monthly podcast with its sister publication, CURE, and launching its very own: “Oncology Nursing News: The Vitals.”

      Starting in June, we will publish a monthly podcast where we’ll talk to experts on the latest and greatest in oncology nursing. But before we upload our first interview, we need our readers’ help deciding on a logo, as well as topics to discuss.

      Take the survey and have your voice heard! Do you choose logo A, B, or C? Also, let us know what you want from an oncology nursing podcast: Discussion of adverse event management? The latest clinical updates? Nursing career-related topics, such as burnout and continuing education?

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      4 experts in this video
      4 experts in this video
      4 experts in this video
      4 experts in this video
      Image of a woman with light brown hair wearing glasses with a blue background
      Image of a woman wearing glasses in front of a blue background
      Image of a woman with glasses in front of a blue background
      Image of a man in a suit smiling in front of an Oncology Nursing News background
      Related Content
      Photo of the FDA office's sign

      Sunvozertinib Granted FDA Accelerated Approval in EGFR Exon 20+ NSCLC

      Bridget Hoyt
      July 2nd 2025
      Article

      Sunvozertinib has received accelerated approval for use in advanced or metastatic non–small lung cancer harboring EGFR exon 20 insertion mutations.

      The Vitals

      What New Cancer Drugs Were Approved in 2023?

      Lindsay Fischer
      January 1st 2024
      Podcast

      In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

      Image of a laptop with the words "FDA Food and Drug Adminstration" visible

      Oncology Drugs Approved by the FDA in June

      Bridget Hoyt
      July 2nd 2025
      Article

      Oncologic therapies approved in June included indications in genitourinary, lung, and hematologic, and head and neck cancers.

      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      December 14th 2023
      Podcast

      Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

      Graphic of a pair of lungs with tumors

      ICI Rechallenge With Anlotinib May Benefit Pretreated ES-SCLC

      Roman Fabbricatore
      July 1st 2025
      Article

      Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated with prior immunotherapy.

      Photo of a woman with brown hair and bangs, surrounded by a blue border

      AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

      Michelle Kirschner, RN, MSN, ACNP, APRN-BC
      June 30th 2025
      Article

      Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

      Related Content
      Photo of the FDA office's sign

      Sunvozertinib Granted FDA Accelerated Approval in EGFR Exon 20+ NSCLC

      Bridget Hoyt
      July 2nd 2025
      Article

      Sunvozertinib has received accelerated approval for use in advanced or metastatic non–small lung cancer harboring EGFR exon 20 insertion mutations.

      The Vitals

      What New Cancer Drugs Were Approved in 2023?

      Lindsay Fischer
      January 1st 2024
      Podcast

      In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

      Image of a laptop with the words "FDA Food and Drug Adminstration" visible

      Oncology Drugs Approved by the FDA in June

      Bridget Hoyt
      July 2nd 2025
      Article

      Oncologic therapies approved in June included indications in genitourinary, lung, and hematologic, and head and neck cancers.

      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      December 14th 2023
      Podcast

      Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

      Graphic of a pair of lungs with tumors

      ICI Rechallenge With Anlotinib May Benefit Pretreated ES-SCLC

      Roman Fabbricatore
      July 1st 2025
      Article

      Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated with prior immunotherapy.

      Photo of a woman with brown hair and bangs, surrounded by a blue border

      AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

      Michelle Kirschner, RN, MSN, ACNP, APRN-BC
      June 30th 2025
      Article

      Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

      Latest Conference Coverage

      Allogenic CAR T-Cell Agent Safe, Active in Heavily Pretreated RCC

      No Survival, Recurrence Benefit With Aspirin in CRC Liver Metastases

      Relacorilant Combo Sustains Ovarian Cancer Benefit Post Platinum Break

      Genomic Changes May Drive Sotorasib KRAS G12C+ Combo Resistance in CRC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.